* Registration is required to view this article.
|* Dr Paul Jourdan quoted in Morningstar's article "Why You Should Invest in Dynamic Companies".
|Dr Paul Jourdan nominated for ESG Clarity's 2020 ESG Fund Managers of the Future
|* Citywire report on Amati planning to take a stake in HeiQ when the antiviral textiles group floats next month.
|"Amati AIM VCT succeeds with over-allotment fundraise" reports Investment Week.
|TB Amati listed as one of the funds outperforming their benchmark by the most over the past 10 years in FE Trustnet's article.
|Darius McDermott, managing director at Chelsea Financial Services highlights TB Amati UK Smaller Companies Fund as a good place for investors to look for long-term value in This is Money's article.
|Merryn Somerset Webb talks to Dr Paul Jordan, Anna Macdonald and Dr Gareth Blades about some of their favourite small UK companies on The Money Week's Podcast.
|Dr Paul Jourdan speaks to The Association of Investment Companies (AIC) on 25 years of VCTs.
|Gareth Blades, analyst at Amati Global Investors, speaks to This is Money on the current challenges of valuing healthcare companies
|TB Amati UK Smaller Companies Fund highlighted in This is Money's article on small stocks
|* Citywire highlight TB Amati's addition to Hargreave Lansdown's Wealth Shortlist.
|Hargreaves Lansdown has selected TB Amati UK Smaller Companies Fund as the first addition to its new Wealth Shortlist reports Investment Week.
|TB Amati UK Smaller Companies Fund recognised as leading the pack in performance in the UK Smaller Companies Asset Class by Interactive Investor.
|David Stevenson quoted in Citywire's article on smaller companies raising funds during lockdown.
|Paul Jourdan has hailed Synairgen's announcement of a positive trial of its COVID-19 drug as a 'truly fantastic' result that is 'better than anyone could have hoped for' reports Citywire.
|Money Observer highlights TB Amati UK Smaller Companies Funds as one of the top five UK fund performers four years on from the Brexit vote.
|FundCalibre managing director Darius McDermott highlights TB Amati as one of the funds best for tapping into the AIM market opportunities in Trustnet's article.
|Anna Macdonald is interviewed by Citywire for their article "Top small cap investors use AIM edge to back UK Gaming".
|Darius McDermott highlights TB Amati as one of his fund picks in Investment Week's article "The AIM market at 25: Successes, failures and new opportunities".
|Dr Paul Jourdan speaks to Citywire on his top three picks from the Alternative Investment Market (AIM).
|Managers of Wealth report on Amati's further sponsorship of ABC of Opera, winner of the 2019 Amati Guildhall Creative Entrepreneurs' Award.
|Consumer stocks, repatriation flights and sea swims: Anna Macdonald speaks to ESG Clarity.
|Dr Paul Joudan quoted in Money Observer's article "25 years of AIM: how the junior market has become less risky".
|"Homeschooling is even harder than getting the kids home from Kenya!" Anna Macdonald speaks to Citywire.
|Trustnet highlight TB Amati as one of three funds to buy now for a UK bounceback.
|Dr Paul Jourdan speaks to FundCalibre on lockdown behaviours benefiting UK small-caps.
|Amati AIM VCT latest fundraising has reached its targeted £25 million capacity reports Angel News.
|Fundeye report on Amati AIM VCT.
|* TB Amati UK Smaller Companies Fund one of the best performing funds in April 2020 reports Morningstar.
|"We should not assume we will have a vaccine for this" Dr Paul Jourdan speaks to Will Robins at Citywire.
|Anna Macdonald speaks to Shares Magazine about the small caps Amati have been buying and selling.
|The Sunday Times highlight TB Amati UK Smaller Companies Fund.
|Managers of Wealth report on Amati's recent TB Amati UK Smaller Companies Fund Portfolio Update webinar.
|"Don't write off UK small caps" Darius McDermott highlights TB Amati in his article for Portfolio Adviser
|"What is the right way to approach executive pay during the coronavirus crisis?" Dr Paul Jourdan speaks to Natalie Kenway in Portfolio Adviser's article.
|Dr Paul Jourdan offers his views to ESG Clarity in their article "Executive pay: What is the right thing to do in times of crisis?".
|"This particular crisis tends to favour medical and technology companies", Dr Paul Jourdan speaks to Citywire
|"The healthcare sector is facing the equivalent of a very accelerated dotcom boom" Amati CEO, Dr Paul Jourdan speaks to The Mail on Sunday
|Dr Paul Jourdan quoted in ESG Clarity's article "Shining a light on companies helping society move through covid19 crisis - part two"
|Dr Paul Jourdan speaks to Fundeye on portfolio companies Byotrol, Tristel and Synairgen.
|FE Trustnet list TB Amati UK Smaller Companies Fund as one of the best performing funds over 3 years in the recovery from the financial crisis.
|Amati backs COVID-19 in clinical trial with investment in Synairgen reports Managers of Wealth.
|FundCalibre award TB Amati UK Smaller Companies Fund an Elite Rating.
|Portfolio Adviser report on TB Amati UK Smaller Companies Fund being awarded a FundCalibre Elite Rating.
|Morningstar highlight TB Amati as a good long term performing fund.
|Interactive Investor publish Dr Paul Jourdan's comments on the current climate.
|Amati AIM VCT highlighted in Money Observer's article "Why VCTs are retaining their pulling power".
|FE Trustnet list TB Amati as the third most consistent fund in the UK small cap sector over the past ten years.
|Managers of Wealth report on Amati's appointment of Colin Thomson as Sales Director.
|UK equities: What the 'first stage of Brexit clarity' means for investors - Anna Macdonald speaks to Investment Week.
|Moneywise highlight TB Amati UK Smaller Companies Fund as one of twenty funds to add value.
|What Investment highlight Amati AIM VCT as one of the VCT recommendations ahead of the tax year end.
|TB Amati highlighted in Citywire's article "IFAs search for balance in clients' climate crisis portfolios".
|Why I'm Backing UK Smaller Companies" Dr Paul Jourdan speaks to Morningstar.
|David Stevenson speaks to FE Trustnet on three stocks that Amati is using to benefit from the growing appetite for alternative assets.
|"The sure sign we've found a winning AIM stock" Amati fund manager, David Stevenson speaks to FE Trustnet.
|Dr Paul Jourdan offers his views in Morningstar's article "Is Brexit an Opportunity for VCTs?"
|Anna Macdonald is interviewed by Investors Chronicle on UK equities.
|Dr Paul Jourdan speaks to Money Observer on potential changes to the IHT exemption on AIM shares.
|FT Adviser highlight Dr Paul Jourdan's comments on the recent decline in LSE listings.
|Dr Paul Jourdan quoted in Forbes' article "The Amazing Shrinking Markets".
|FE Trustnet highlight TB Amati as one of the UK Smaller Companies funds most attracting flows in December 2019.
|"How VCT investments are pulling their weight in post-Brexit Britain" - Watch the video of the AIC's recent VCT media roundtable that Dr Paul Jourdan recently participated in.
|Dr Paul Jourdan quoted in Money Observer on the flows into UK equity funds in the weeks leading up to the general election.
|Dr Paul Jourdan offers his views in Citywire's article "2020: A Defining Year for Tech".
|Anna Macdonald quoted in Citywire's article on Fevertree.
|Dr Paul Jourdan speaks to Citywire on The Alternative Investment Market (AIM).
|Portfolio Adviser report on Amati Global Investor's growth in assets.
|Dr Paul Jourdan discusses recent investment activity, the effect of Brexit on smaller companies and their overall outlook for the sector at the Association of Investment Companies (AIC) VCT media roundtable.
|TB Amati UK Smaller Companies Fund the 6th best performing fund of the millennium reports FE Trustnet
|TB Amati UK Smaller Companies Fund one of the best performing funds over five years on Interactive Investor's Super 60 rated list.
|Amati AIM VCT highlighted in The Telegraph's article "Tax-savvy investors set to break venture capital trust sales record"
|Citywire reports on the top funds in December 2019 with TB Amati UK Smaller Companies fund in eighth position.
|FE Trustnet highlight TB Amati UK Smaller Companies Fund as one of the best performing funds of the 2010s.
|TB Amati UK Smaller Companies Fund one of the top performing funds in December 2019 reports Fundeye.
|Money Observer list TB Amati as one of the top 10 most popular investment funds in December 2019.
|FE Trustnet highlight TB Amati as one of 3 top rated UK Smaller Companies funds that investors can hold together without worrying about increasing concentration risk.
|Citywire speak to Amati on the successful performance of TB Amati UK Smaller Companies Fund.